Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting the mast cell in asthma.

Peter Peachell1

  • 1Molecular Pharmacology, University of Sheffield, Royal Hallamshire Hospital (Floor M), Glossop Road, Sheffield S10 2JF, UK. p.t.peachell@shef.ac.uk

Current Opinion in Pharmacology
|May 24, 2005
PubMed
Summary

Stabilizing pulmonary mast cells is key for effective asthma treatment. Current therapies inadequately control these cells, highlighting the need for new asthma treatments targeting mast cell activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pellino-1 Regulates Immune Responses to <i>Haemophilus influenzae</i> in Models of Inflammatory Lung Disease.

Frontiers in immunology·2019
Same author

An Optimized Protocol for the Isolation and Functional Analysis of Human Lung Mast Cells.

Frontiers in immunology·2018
Same author

Regulation of mast cells by beta-agonists.

Clinical reviews in allergy & immunology·2006
See all related articles

Area of Science:

  • Pulmonary immunology
  • Allergy and immunology
  • Respiratory medicine

Background:

  • Pulmonary mast cells play a crucial role in mediating asthma.
  • Current asthma treatments like bronchodilators and steroids have limitations in controlling mast cell activity.

Purpose of the Study:

  • To evaluate the therapeutic potential of targeting mast cell activity in asthma.
  • To assess novel asthma therapies based on their mast cell-directed activities.

Main Methods:

  • Review of prospective and potential asthma therapies.
  • Analysis of mast cell-directed activities of various treatment strategies.

Main Results:

  • Existing frontline asthma therapies inadequately control pulmonary mast cell activity.
  • Prospective therapies (anti-IgE, adenosine receptor antagonists, PDE inhibitors) and potential therapies (chemokine receptor antagonists, TLR antagonists) show variable mast cell activities.

Conclusions:

  • Targeting pulmonary mast cells offers a promising therapeutic avenue for asthma.
  • Asthma treatment strategies with more effective mast cell targeting are likely to yield greater clinical benefits.

Related Experiment Videos